The study reported that HER-2 gene amplification was observed in 26.3% of KRAS and v-raf murine sarcoma viral oncogene homolog B (BRAF) wild type colorectal carcinomas in Spanish patients. This evidence concerns the gene KRAS and colorectal carcinoma.